Type to search

Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection | Pharmtech Focus
Freenome Shows Continued Leadership in Colorectal Cancer Research | Pharmtech Focus
New Study Finds Freenome ’s Multiomics Approach Successful in Detecting Pancreatic Cancer | Pharmtech Focus